Step one is not to fire Missling but to bump him up to Chairman and get rid of Jiong Ma. What has she done for us as Chairman of the Board. At the same time announce a new President. Someone who has experience in bringing a drug to market, has done a few partnerships and has the ear of Wall St. A major player in the pharma world. If they really have a revolutionary drug they should be able to attract the talent. We need someone who will not be lying to Wall Street and the retail shareholders. Missling has done that. Want proof? New secret indication starting soon ( for years now ). After JP Morgan the phone was ringing off the hook. Still ringing? Who are those partners. The rollout of the the Alz data 3 years ago was a disaster. Two shareholder lawsuits and another one coming for Missling lies and mistruths. They are far enough along with the drug development to sell the opportunity to a big player in the field. After that I would partner out some of our indications. I know it goes against the selling out to one big pharma one day but I thing that ship has sailed. We will need cash to either do another P3 for both 273 and 371. That cash is not coming via a large partnership right now. There is blood in the water and they will be putting their foot on our throat. They want us dead so someone can pick us up for $5pps.
This company needs a win. A partnership will do that. Going it alone has proven to be too much for this company. When was the last time they brought on new talent to help. Have you noticed the tone of the one real contact at the company lately. He sounds beaten as well. It is not the same old keep on buying we are in good shape. The story I got was well this is biotech, what did you expect. Buy more if it goes into the $2's. How about when is management going to buy some shares on the open market?? They keep telling us to buy but not one of them is buying. Don't even tell me about the 375 shares. We need real leadership who can clearly communicate with the street, the FDA and the EMA. Why do we only have 2 real (low level ) analysts on the conf call. We have the guy who cannot take his phone off of mute and as good as he is we have Jesse. He is not a top tier analysts, he is one of us , a retail shareholder. Our guy struggles to effectively market the company. Our web site is old and tired. Sorry for the rant but we are hanging our hats on the EMA to change their mind. There is a greater chance of them denying this drug than to change. WE are not big pharma with big $$$$ , leverage and politics on our side. Get something big done Missling , we are dying a fast death as you rake in $800K per year and collecting more stock on bullshit goals.
Bullish
AI
Market Data 
Markets 
